[53] The consortium published a white paper entitled „Consortium Recommendations for Advancing Pharmacists“ Patients Care Services and Collaborative Practice Agreements and summarized their recommendations. [18] Advanced pharmacy services under a CPA are described as Collaborative Management of Drug Therapy (MTCT). [a] While the traditional practice for pharmacists is for the judicial authority to recognize drug-related problems (DOP) and suggest solutions for prescription people (e.B.B doctors), pharmacists who offer CDTMs solve them directly when they recognize them. This may include prescribing medications to select and initiate medications to treat a patient`s diagnosed illnesses (as described in the CPA), discontinuing the use of prescription or over-the-counter medications, and modifying a patient`s drug treatment (e.B. B change in strength, frequency, frequency of administration or duration of treatment), assessment of a patient`s response to drug therapy (including drug therapy). , such as.B. a basal metabolic panel) and continuation of drug treatment (with a new prescription). [7] Many functions of patient care – such as initiating, modifying or stopping drug therapy – can be delegated to a pharmacist with a CTA. These features can facilitate the delivery of services, such as: The increasing digitization of health records over the years has helped reduce some of the paperwork.

And the results of 10 years of collaborative practice helped Arizona pharmacists justify themselves for a series of legislative changes in 2011. This year, the National Governors Association released a document containing the code Entitled The Expanded Role of Pharmacists in a Transformed Health Care System, which included general recommendations to ease unnecessary restrictions in collaborative practice laws and regulations. South Carolina does not allow pharmacists to change their prescriptions. PAs may provide medical services under written practice directions under medical supervision. The State Medical Council must approve the proposed scope of the practice guidelines. S.C. Code Ann. §40-47-938 John D. Hill, Pharm.D., M.S., BCPS, Joseph M. Hill, M.A., Nicholas J.

Gentile, B.A. A review of state pharmacist collaborative practice laws, American Journal of Health-System Pharmacy, Volume 73, Issue 18, September 15, 2016, Pages 1467-1472, doi.org/10.2146/ajhp160269 Collaborative Practice Agreements (CPA) create formal practical relationships between pharmacists and prescribing physicians. CPAs can benefit from collaborative care by defining functions that, in addition to the pharmacist`s usual practice, are delegated to the pharmacist by the cooperative prescribing physician under the negotiated terms set out in the agreement. Arizona CPAs apply to pharmacists and individual practitioners, who are legally referred to as „providers.“ Providers include established doctors or nurses. The CPA must indicate the condition of the disease, the medications, the conditions of notification to the supplier and the laboratory tests that the pharmacist can order. Pharmacists may monitor or modify a patient`s drug treatment in accordance with the CPA, provided that the provider and pharmacist have a reciprocal relationship between the patient and the physician and patient. [25] To participate in CPAs, pharmacists must be able to assess their patients` health status, implement a pharmaceutical care plan, communicate with stakeholders, and monitor patient progress. This also includes determining when to intervene in a patient`s drug treatment. [26] Pharmacists may obtain registration information from organizations approved by the Pharmacy Council. [26] Some states only allow pharmacists who practice in health care facilities and not in community pharmacies to accept CPAs. Regardless of the practice they ultimately choose, all pharmacists receive the same training at pharmacy school, Weaver said. „It`s about the patient and the practitioner, not where the practitioner practices.“ CPAs are one of the advocacy priorities of professional pharmacy organizations.

In January 2012, the American Pharmacists Association (APhA) brought together a consortium of pharmacy, medical and nursing professionals from 12 countries to discuss the integration of CPAs into daily clinical practice. The CDTM is defined as: „a collaborative practice agreement between one or more physicians and pharmacists under which qualified pharmacists working under a defined protocol are authorized to assume professional responsibility for various functions, including patient assessment; order laboratory tests related to drug therapy; and selection, initiation, monitoring, continuation and adaptation of treatment regimens. „1 CDTM programs were originally developed by the Native American Health Service in the 1970s and have been increasingly adopted and developed by the state.

Categories: Allgemein